Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609414 · ClinicalTrials.gov registry record
Albumin Use in Burn Patients
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 460
- Enrollment target
NCT00609414: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00609414 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 460 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00609414 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 460 participants
- Enrollment target
Study Summary
This is a study of why and how physicians use albumin during the first 72 hours after a burn injury.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-10 |
What the finished NCT00609414 record still lists
NCT00609414 is an observational study that tracks outcomes without assigning an intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00609414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00609414 about?
NCT00609414 is a clinical study titled "Albumin Use in Burn Patients". This is a study of why and how physicians use albumin during the first 72 hours after a burn injury.
What is the current status of trial NCT00609414?
This trial is currently completed. The enrollment target is 460 participants. The study started on 2005-01. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00609414?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
- NCT04621279 · 460 participants
Cool Prime Comparative Effectiveness Study for Mild HIE
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia